Ionis’s ION373 an Orphan Drug in U.S. for a uncommon neurodegenerative illness (NASDAQ:IONS)

0
37

The FDA has designated Orphan Drug standing to Ionis Prescription drugs’s (NASDAQ:IONS) ION373 for the therapy of Alexander illness, a uncommon neurodegenerative illness, characterised by the destruction of the myelin sheath (fatty protecting that protects the nerve fiber and helps sign conduction).

Alexander illness is brought on by a mutation in a protein leading to overproduction of glial fibrillary acidic protein (GFAP) within the mind, and ION373 is antisense medication designed to cease the mutated gene from producing extra GFAP.

LEAVE A REPLY

Please enter your comment!
Please enter your name here